Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 14.24 Billion USD | 12.29% |
| 2022 | 12.68 Billion USD | 6.68% |
| 2021 | 11.88 Billion USD | 19.92% |
| 2020 | 9.91 Billion USD | -7.66% |
| 2019 | 10.73 Billion USD | 9.28% |
| 2018 | 9.82 Billion USD | 8.57% |
| 2017 | 9.04 Billion USD | 7.89% |
| 2016 | 8.38 Billion USD | 12.16% |
| 2015 | 7.47 Billion USD | 1.31% |
| 2014 | 7.38 Billion USD | 3.32% |
| 2013 | 7.14 Billion USD | -1.46% |
| 2012 | 7.24 Billion USD | -4.89% |
| 2011 | 7.62 Billion USD | -2.36% |
| 2010 | 7.8 Billion USD | -4.67% |
| 2009 | 8.18 Billion USD | 1.71% |
| 2008 | 8.05 Billion USD | -3.67% |
| 2007 | 8.35 Billion USD | 6.85% |
| 2006 | 7.82 Billion USD | 24.48% |
| 2005 | 6.28 Billion USD | 11.72% |
| 2004 | 5.62 Billion USD | 61.8% |
| 2003 | 3.47 Billion USD | 19.08% |
| 2002 | 2.91 Billion USD | 9.2% |
| 2001 | 2.67 Billion USD | 0.34% |
| 2000 | 2.66 Billion USD | -6.26% |
| 1999 | 2.84 Billion USD | 27.24% |
| 1998 | 2.23 Billion USD | 19.3% |
| 1997 | 1.87 Billion USD | 28.06% |
| 1996 | 1.46 Billion USD | 32.07% |
| 1995 | 1.1 Billion USD | 146.6% |
| 1994 | 448.9 Million USD | 18.1% |
| 1993 | 380.1 Million USD | 20.59% |
| 1992 | 315.2 Million USD | 37.04% |
| 1991 | 230 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.85 Billion USD | 3.52% |
| 2024 Q3 | 4.2 Billion USD | 2.16% |
| 2024 Q2 | 4.12 Billion USD | 6.85% |
| 2023 Q2 | 3.59 Billion USD | 6.2% |
| 2023 Q4 | 3.72 Billion USD | 5.61% |
| 2023 Q1 | 3.38 Billion USD | 4.53% |
| 2023 Q3 | 3.52 Billion USD | -2.0% |
| 2023 FY | 14.24 Billion USD | 12.29% |
| 2022 Q4 | 3.24 Billion USD | 2.27% |
| 2022 FY | 12.68 Billion USD | 6.68% |
| 2022 Q3 | 3.17 Billion USD | -2.28% |
| 2022 Q1 | 3.02 Billion USD | -3.23% |
| 2022 Q2 | 3.24 Billion USD | 7.2% |
| 2021 Q2 | 3.07 Billion USD | 11.81% |
| 2021 Q1 | 2.75 Billion USD | 1.62% |
| 2021 Q4 | 3.12 Billion USD | 6.65% |
| 2021 Q3 | 2.93 Billion USD | -4.71% |
| 2021 FY | 11.88 Billion USD | 19.92% |
| 2020 FY | 9.91 Billion USD | -7.66% |
| 2020 Q1 | 2.54 Billion USD | -12.46% |
| 2020 Q2 | 2 Billion USD | -21.23% |
| 2020 Q3 | 2.65 Billion USD | 32.75% |
| 2020 Q4 | 2.7 Billion USD | 1.84% |
| 2019 Q3 | 2.7 Billion USD | 2.89% |
| 2019 FY | 10.73 Billion USD | 9.28% |
| 2019 Q4 | 2.9 Billion USD | 7.31% |
| 2019 Q2 | 2.63 Billion USD | 5.54% |
| 2019 Q1 | 2.49 Billion USD | -2.66% |
| 2018 FY | 9.82 Billion USD | 8.57% |
| 2018 Q3 | 2.39 Billion USD | -3.9% |
| 2018 Q2 | 2.49 Billion USD | 4.67% |
| 2018 Q1 | 2.37 Billion USD | -1.2% |
| 2018 Q4 | 2.56 Billion USD | 7.02% |
| 2017 Q2 | 2.25 Billion USD | 4.49% |
| 2017 FY | 9.04 Billion USD | 7.89% |
| 2017 Q3 | 2.22 Billion USD | -1.55% |
| 2017 Q4 | 2.4 Billion USD | 8.37% |
| 2017 Q1 | 2.16 Billion USD | -1.41% |
| 2016 Q2 | 2.12 Billion USD | 8.25% |
| 2016 Q1 | 1.96 Billion USD | -0.71% |
| 2016 FY | 8.38 Billion USD | 12.16% |
| 2016 Q3 | 2.1 Billion USD | -0.99% |
| 2016 Q4 | 2.19 Billion USD | 4.09% |
| 2015 Q1 | 1.76 Billion USD | -6.31% |
| 2015 Q2 | 1.84 Billion USD | 4.24% |
| 2015 Q3 | 1.88 Billion USD | 2.44% |
| 2015 Q4 | 1.97 Billion USD | 4.77% |
| 2015 FY | 7.47 Billion USD | 1.31% |
| 2014 FY | 7.38 Billion USD | 3.32% |
| 2014 Q4 | 1.88 Billion USD | 2.22% |
| 2014 Q3 | 1.84 Billion USD | -1.44% |
| 2014 Q2 | 1.87 Billion USD | 5.58% |
| 2014 Q1 | 1.77 Billion USD | -3.48% |
| 2013 Q4 | 1.83 Billion USD | 5.94% |
| 2013 Q1 | 1.76 Billion USD | -3.29% |
| 2013 Q2 | 1.8 Billion USD | 2.73% |
| 2013 FY | 7.14 Billion USD | -1.46% |
| 2013 Q3 | 1.73 Billion USD | -4.09% |
| 2012 Q2 | 1.82 Billion USD | -2.04% |
| 2012 Q1 | 1.86 Billion USD | 0.97% |
| 2012 FY | 7.24 Billion USD | -4.89% |
| 2012 Q4 | 1.82 Billion USD | 4.96% |
| 2012 Q3 | 1.73 Billion USD | -5.09% |
| 2011 FY | 7.62 Billion USD | -2.36% |
| 2011 Q1 | 1.92 Billion USD | -3.85% |
| 2011 Q2 | 1.97 Billion USD | 2.6% |
| 2011 Q3 | 1.87 Billion USD | -5.11% |
| 2011 Q4 | 1.84 Billion USD | -1.39% |
| 2010 Q3 | 1.91 Billion USD | -0.62% |
| 2010 Q1 | 1.96 Billion USD | -5.72% |
| 2010 Q2 | 1.92 Billion USD | -1.63% |
| 2010 Q4 | 2 Billion USD | 4.49% |
| 2010 FY | 7.8 Billion USD | -4.67% |
| 2009 Q1 | 2.01 Billion USD | 0.4% |
| 2009 Q4 | 2.07 Billion USD | 2.67% |
| 2009 Q3 | 2.02 Billion USD | -2.36% |
| 2009 Q2 | 2.07 Billion USD | 3.18% |
| 2009 FY | 8.18 Billion USD | 1.71% |
| 2008 Q4 | 2 Billion USD | 1.21% |
| 2008 Q3 | 1.97 Billion USD | -2.27% |
| 2008 Q2 | 2.02 Billion USD | -1.08% |
| 2008 Q1 | 2.04 Billion USD | -4.97% |
| 2008 FY | 8.05 Billion USD | -3.67% |
| 2007 FY | 8.35 Billion USD | 6.85% |
| 2007 Q4 | 2.15 Billion USD | 5.13% |
| 2007 Q3 | 2.04 Billion USD | -1.11% |
| 2007 Q2 | 2.07 Billion USD | -0.72% |
| 2007 Q1 | 2.08 Billion USD | 1.02% |
| 2006 Q4 | 2.06 Billion USD | 1.92% |
| 2006 Q3 | 2.02 Billion USD | -3.98% |
| 2006 Q2 | 2.11 Billion USD | 30.25% |
| 2006 Q1 | 1.62 Billion USD | 5.19% |
| 2006 FY | 7.82 Billion USD | 24.48% |
| 2005 Q4 | 1.54 Billion USD | 1.92% |
| 2005 Q3 | 1.51 Billion USD | -6.56% |
| 2005 Q2 | 1.61 Billion USD | 0.12% |
| 2005 FY | 6.28 Billion USD | 11.72% |
| 2005 Q1 | 1.61 Billion USD | 0.94% |
| 2004 Q2 | 1.46 Billion USD | 34.94% |
| 2004 Q4 | 1.6 Billion USD | 7.96% |
| 2004 FY | 5.62 Billion USD | 61.8% |
| 2004 Q1 | 1.08 Billion USD | 15.23% |
| 2004 Q3 | 1.48 Billion USD | 1.51% |
| 2003 Q4 | 939 Million USD | 7.19% |
| 2003 Q2 | 854 Million USD | 5.82% |
| 2003 Q1 | 807 Million USD | -0.86% |
| 2003 FY | 3.47 Billion USD | 19.08% |
| 2003 Q3 | 876 Million USD | 2.58% |
| 2002 FY | 2.91 Billion USD | 9.2% |
| 2002 Q4 | 814 Million USD | 12.74% |
| 2002 Q3 | 722 Million USD | 1.98% |
| 2002 Q2 | 708 Million USD | 4.89% |
| 2002 Q1 | 675 Million USD | -0.3% |
| 2001 Q2 | 672 Million USD | 2.75% |
| 2001 Q4 | 677 Million USD | 1.04% |
| 2001 FY | 2.67 Billion USD | 0.34% |
| 2001 Q1 | 654 Million USD | 2.51% |
| 2001 Q3 | 670 Million USD | -0.3% |
| 2000 Q3 | 652 Million USD | -6.19% |
| 2000 Q1 | 679 Million USD | -5.3% |
| 2000 Q2 | 695 Million USD | 2.36% |
| 2000 FY | 2.66 Billion USD | -6.26% |
| 2000 Q4 | 638 Million USD | -2.15% |
| 1999 Q1 | 708 Million USD | 3.74% |
| 1999 Q4 | 717 Million USD | 3.76% |
| 1999 Q3 | 691 Million USD | -4.82% |
| 1999 Q2 | 726 Million USD | 2.54% |
| 1999 FY | 2.84 Billion USD | 27.24% |
| 1998 FY | 2.23 Billion USD | 19.3% |
| 1998 Q1 | 470 Million USD | -4.7% |
| 1998 Q2 | 505.7 Million USD | 7.6% |
| 1998 Q3 | 575.4 Million USD | 13.78% |
| 1998 Q4 | 682.5 Million USD | 18.61% |
| 1997 Q4 | 493.2 Million USD | 3.88% |
| 1997 FY | 1.87 Billion USD | 28.06% |
| 1997 Q1 | 399.2 Million USD | -2.32% |
| 1997 Q2 | 473.7 Million USD | 18.66% |
| 1997 Q3 | 474.8 Million USD | 0.23% |
| 1996 Q1 | 322.4 Million USD | -25.23% |
| 1996 Q4 | 408.7 Million USD | 9.37% |
| 1996 Q3 | 373.7 Million USD | 4.62% |
| 1996 Q2 | 357.2 Million USD | 10.79% |
| 1996 FY | 1.46 Billion USD | 32.07% |
| 1995 Q3 | 232.8 Million USD | 2.42% |
| 1995 Q4 | 431.2 Million USD | 85.22% |
| 1995 FY | 1.1 Billion USD | 146.6% |
| 1995 Q1 | 215.7 Million USD | 77.38% |
| 1995 Q2 | 227.3 Million USD | 5.38% |
| 1994 Q4 | 121.6 Million USD | 8.38% |
| 1994 Q2 | 109.9 Million USD | 4.37% |
| 1994 Q1 | 105.3 Million USD | 4.15% |
| 1994 Q3 | 112.2 Million USD | 2.09% |
| 1994 FY | 448.9 Million USD | 18.1% |
| 1993 Q1 | 88.9 Million USD | 5.33% |
| 1993 Q2 | 94.4 Million USD | 6.19% |
| 1993 Q3 | 95.6 Million USD | 1.27% |
| 1993 Q4 | 101.1 Million USD | 5.75% |
| 1993 FY | 380.1 Million USD | 20.59% |
| 1992 FY | 315.2 Million USD | 37.04% |
| 1992 Q4 | 84.4 Million USD | 3.05% |
| 1992 Q3 | 81.9 Million USD | 7.34% |
| 1992 Q2 | 76.3 Million USD | 5.1% |
| 1992 Q1 | 72.6 Million USD | 13.79% |
| 1991 Q1 | 50.5 Million USD | 0.0% |
| 1991 Q4 | 63.8 Million USD | 6.51% |
| 1991 Q3 | 59.9 Million USD | 7.16% |
| 1991 FY | 230 Million USD | 0.0% |
| 1991 Q2 | 55.9 Million USD | 10.69% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 64.497% |
| Allurion Technologies Inc. | 53.46 Million USD | -26533.25% |
| Artivion, Inc. | 354 Million USD | -3922.553% |
| Avanos Medical, Inc. | 673.3 Million USD | -2014.956% |
| Butterfly Network, Inc. | 65.9 Million USD | -21508.498% |
| Butterfly Network, Inc. | 65.9 Million USD | -21508.498% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | -433.081% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -200350.45% |
| CONMED Corporation | 1.24 Billion USD | -1047.504% |
| Edwards Lifesciences Corporation | 6 Billion USD | -137.144% |
| Paragon 28, Inc. | 216.38 Million USD | -6480.741% |
| Glaukos Corporation | 314.71 Million USD | -4424.786% |
| Globus Medical, Inc. | 1.56 Billion USD | -807.888% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -2179.133% |
| Integer Holdings Corporation | 1.59 Billion USD | -791.854% |
| Medtronic plc | 32.36 Billion USD | 56.0% |
| Nevro Corp. | 425.17 Million USD | -3249.217% |
| Owlet, Inc. | 54.01 Million USD | -26265.488% |
| Penumbra, Inc. | 1.05 Billion USD | -1245.272% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | -156.623% |
| Sonendo, Inc. | 43.86 Million USD | -32363.239% |
| STERIS plc | 5.13 Billion USD | -177.113% |
| Stryker Corporation | 20.49 Billion USD | 30.53% |
| Vapotherm, Inc. | 68.66 Million USD | -20637.159% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | -92.583% |